Xuesong Liu
- Molecular Biology top 0.1%
- Oncology top 0.5%
- Immunology top 0.5%
- Cancer Research top 0.5%
- Epidemiology top 1%
- Co-authors
- Xiaodong WangHua ZouJie YangRonald JemmersonWilliam J. HenzelTsung-I PengKapil N. BhallaDean P. Jones
- Topics
- PARP inhibition in cancer therapy (17 papers)Cell death mechanisms and regulation (16 papers)DNA Repair Mechanisms (16 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xuesong Liu
219 papers receiving 20.9k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Molecular Biology 15.5k
- Oncology 3.8k
- Immunology 3.4k
- Cancer Research 2.3k
- Epidemiology 2.1k
Countries citing papers authored by Xuesong Liu
This map shows the geographic impact of Xuesong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesong Liu more than expected).
Fields of papers citing papers by Xuesong Liu
This network shows the impact of papers produced by Xuesong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesong Liu. The network helps show where Xuesong Liu may publish in the future.
Co-authorship network of co-authors of Xuesong Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Xuesong Liu. A scholar is included among the top collaborators of Xuesong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuesong Liu. Xuesong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 19 | |
| 6 | 13 | |
| 7 | 14 | |
| 8 | 10 | |
| 9 | 11 | |
| 10 | 6 | |
| 11 | 21 | |
| 12 | 97 | |
| 13 | 73 | |
| 14 | 29 | |
| 15 | 34 | |
| 16 | 80 | |
| 17 | 111 | |
| 18 | 77 | |
| 19 | 5 | |
| 20 | Transition from chronic stunning to hibernation and further on to necrosis in a porcine model of chronic ischemia identified with PET | 1 |
About Xuesong Liu
Xuesong Liu is a scholar working on Immunology, Cancer Research and Oncology, having authored 231 papers that have together received 21.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (17 papers), Cell death mechanisms and regulation (16 papers) and DNA Repair Mechanisms (16 papers). The work is most often cited by research in Molecular Biology (15.5k citations), Immunology (3.4k citations) and Cancer Research (2.3k citations). Xuesong Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaodong Wang, Hua Zou, Jie Yang, Ronald Jemmerson, William J. Henzel, Tsung-I Peng, Kapil N. Bhalla, Dean P. Jones, Ana Maria Ibrado and Jiyang Cai. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.